Lansoprazole Market: Global Industry Analysis and Forecast (2024-2030)

Lansoprazole Market size was valued at US$ 1.89 Bn. in 2023 and the total revenue is expected to grow at a CAGR of 5.8% through 2024 to 2030, reaching nearly US$ 2.81 Bn.
Lansoprazole Market Overview:
The Lansoprazole Market is expected to reach US$ 2.81 Bn. by 2030. Lansoprazole is a medication that is used to treat disorders in which the stomach has too much acid. It treats duodenal and stomach ulcers, NSAID-induced gastric ulcers, erosive esophagitis, and gastroesophageal reflux disease (GERD). Capsules, OD Tablet, and Botulinum toxin are the product types of the Lansoprazole.To know about the Research Methodology :- Request Free Sample Report
Dynamics:
Lansoprazole is a proton pump inhibitor that inhibits the production of gastric acid in the stomach, making it easier to treat a variety of gastric illnesses. Proton pump inhibitors function by blocking the proton pump, which is the important region for H+ ion secretion in the stomach lumen. Proton pump inhibitors bind to the proton pump and deactivate it, preventing H+ ions from being secreted into the stomach lumen and thereby decreasing the formation of gastric acid. Lansoprazole is not like other drugs used to treat gastroesophageal reflux disease, such as antacids, which work by neutralizing the acid produced in the stomach. Lansoprazole works on this process to treat GERD, which is characterized by the backward flow of gastric acid from the stomach, causing symptoms like heartburn and acidity. Prescription brands and over-the-counter medications (OTC) in various formats are both available.

The rise in the incidence of gastroesophageal reflux disease (GERD), gastric ulcers, duodenal ulcers, and other gastric illnesses is driving the global lansoprazole market. Other factors expected to boost the global lansoprazole market during the forecast period include an increase in demand for proton pump inhibitors and ongoing clinical trials for the evaluation of new lansoprazole formulations targeted at increasing the drug's efficiency. However, new medication classes for the treatment of gastric illnesses, such as H2 blockers, antacids, and others, are expected to hamper the global lansoprazole market during the forecast period, as patients prefer these drug classes that provide fast relief from gastroesophageal reflux disease.
Lansoprazole Market Segment Analysis:
Based on the Route of Administration, the market is segmented into Oral, and Intravenous. Oral route of administration segment is expected to hold the largest market share of xx% by 2030. This is due to patients with mild to moderate gastroesophageal reflux disease preferring capsule formulations, low cost of oral capsules, and an increase in the number of manufacturers in the global market supplying lansoprazole in capsule forms. These are the factors that are expected to drive the growth of the Oral route of administration segment in the Lansoprazole Market during the forecast period.

Based on the Product Type, the market is segmented into Capsules, OD Tablet, and Botulinum toxin. Botulinum toxin segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2024-2030. Botulin toxin injections reduce wrinkles by relaxing the muscles that cause them. Migraines, hyperhidrosis, overactive bladder, and eye difficulties are among the medical ailments that can be treated with these injections. Botox is often recommended by doctors for pain relief. Botox relaxes and relieves pain by blocking nerve signals that control muscle action.

The neurotoxins utilised in Botox are produced by a bacterium called Clostridium botulinum. For medical injections, healthcare providers utilise a specific type of bacteria (type A). Botulinum toxins are found in soil and contaminated foods in nature. Botulism can be contracted if high doses of botulinum toxins are consumed or if the germs enter a wound. Breathing is affected by this significant nervous system illness. Botox is manufactured in a lab for maximum safety and efficacy. The botulinum toxins are diluted and sterilised so that they do not induce botulism.
Lansoprazole Market Regional Insights:
North American region is expected to dominate the Lansoprazole Market during the forecast period 2024-2030. The North American region is expected to hold the largest market share of xx% by 2030. This is due to an increase in the frequency of GERD in the United States and a larger demand in the region for sustained release proton pump inhibitor medicines. According to the World Gastroenterology Organisation, the prevalence of GERD in Eastern Asia ranged from 2.5 percent to 6.6 percent in 2015, while in North America it ranged from 13.8 percent to 25.8%. These are the factors that are expected to drive the growth of the North American region in the Lansoprazole Market during the forecast period.

The objective of the report is to present a comprehensive analysis of the Global Lansoprazole Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The reports also help in understanding the Global Lansoprazole Market dynamic, structure by analyzing the market segments and projecting the Global Lansoprazole Market size. Clear representation of competitive analysis of key players by Technique, price, financial position, product portfolio, growth strategies, and regional presence in the Lansoprazole Market make the report investor’s guide.
Lansoprazole Market Scope: Inquiry Before Buying



Global Lansoprazole Market


Report Coverage
Details


Base Year:
2023
Forecast Period:
2024-2030


Historical Data:
2018 to 2023
Market Size in 2023:
US $ 1.89 Bn.


Forecast Period 2024 to 2030 CAGR:
5.8%
Market Size in 2030:
US $ 2.81 Bn.


 Segments Covered:
by Product Type
Capsules
OD Tablet
Botulinum toxin


by Application
Male
Female


by Route of Administration
Oral
Intravenous



Lansoprazole Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Lansoprazole Market, Key Players
1. Takeda Pharmaceutical
2. Teva Pharms
3. Sandoz
4. GSK
5. Dr. Reddy's
6. Pfizer
7. Taj Pharma
8. Mylan
9. Cisen Pharmaceutical
10.Lepu Pharmaceuticals
11.Nang Kuang Pharmaceutical
12.Luoxin Biotechnology
13.Beijing Honglin Pharma
14.Suzhou YUSHI Pharmaceutical Co.
15.Changzhou Siyao Pharmaceuticals
16.Perrigo Company plc
17.Sun Pharmaceutical Industries Ltd.

Frequently Asked Questions:

1] Which region is expected to hold the highest share in the Lansoprazole Market?
Ans. North America is expected to hold the highest share in the Lansoprazole Market.

2] Who are the top key players in the Lansoprazole Market?
Ans. Takeda Pharmaceutical, Teva Pharms, Sandoz, GSK, Dr. Reddy's, and Pfizer are the top key players in the Lansoprazole Market.

3] Which segment is expected to hold the largest market share in the Lansoprazole Market by 2030?
Ans. Oral route of administration segment is expected to hold the largest market share in the Lansoprazole Market by 2030.

4] What is the market size of the Lansoprazole Market by 2030?
Ans. The market size of the Lansoprazole Market is expected to reach US $ 2.81 Bn. by 2030

5] What was the market size of the Lansoprazole Market in 2023?
Ans. The market size of the Lansoprazole Market was worth US $1.89 Bn. in 2023